Published in Drug Dev Res on November 01, 2014
WHO-EORTC classification for cutaneous lymphomas. Blood (2005) 12.14
Dermoscopy of pigmented skin lesions: results of a consensus meeting via the Internet. J Am Acad Dermatol (2003) 4.15
Integrative responses to IL-17 and TNF-α in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis. J Invest Dermatol (2010) 2.09
The role of antinuclear autoantibodies in patients with psoriasis treated with anti-tumor necrosis factor-alpha agents: a retrospective long-term study. J Am Acad Dermatol (2012) 2.01
The cost effectiveness of biologic therapy for the treatment of chronic plaque psoriasis in real practice settings in Italy. BioDrugs (2014) 1.99
Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulins: multicenter retrospective analysis of 48 consecutive cases. Arch Dermatol (2003) 1.95
Granulomatous mycosis fungoides and granulomatous slack skin: a multicenter study of the Cutaneous Lymphoma Histopathology Task Force Group of the European Organization For Research and Treatment of Cancer (EORTC). Arch Dermatol (2008) 1.78
Three-point checklist of dermoscopy. A new screening method for early detection of melanoma. Dermatology (2004) 1.74
A regulatory feedback loop involving p63 and IRF6 links the pathogenesis of 2 genetically different human ectodermal dysplasias. J Clin Invest (2010) 1.73
Impact of body mass index and obesity on clinical response to systemic treatment for psoriasis. Evidence from the Psocare project. Dermatology (2008) 1.70
Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas. J Clin Oncol (2006) 1.70
Altered penetration of polyethylene glycols into uninvolved skin of atopic dermatitis patients. J Invest Dermatol (2006) 1.62
WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects. J Cutan Pathol (2005) 1.51
The p73 gene is an anti-tumoral target of the RARbeta/gamma-selective retinoid tazarotene. J Invest Dermatol (2004) 1.48
Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis. Nat Med (2009) 1.45
Developmental factor IRF6 exhibits tumor suppressor activity in squamous cell carcinomas. Proc Natl Acad Sci U S A (2011) 1.42
Jumping into the future using teledermoscopy. Skinmed (2003) 1.41
Toxoplasma gondii, HCV, and HBV seroprevalence and co-infection among HIV-positive and -negative pregnant women in Burkina Faso. J Med Virol (2006) 1.38
The spectrum of Spitz nevi: a clinicopathologic study of 83 cases. Arch Dermatol (2005) 1.36
An Italian study on psoriasis and depression. Dermatology (2006) 1.31
Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics. J Am Acad Dermatol (2007) 1.28
Effect of anti-tumor necrosis factor-alpha therapies on body mass index in patients with psoriasis. Pharmacol Res (2008) 1.27
Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis. N Engl J Med (2015) 1.20
Cytotoxic/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force Workshop. Cancer (2003) 1.15
Depressive symptoms and childhood sleep apnea syndrome. Neuropsychiatr Dis Treat (2012) 1.14
The tumor suppressor activity of IKKalpha in stratified epithelia is exerted in part via the TGF-beta antiproliferative pathway. Proc Natl Acad Sci U S A (2008) 1.12
Attenuated cerulein-induced pancreatitis in nuclear factor-kappaB-deficient mice. Lab Invest (2003) 1.10
IKKalpha is a p63 transcriptional target involved in the pathogenesis of ectodermal dysplasias. J Invest Dermatol (2008) 1.10
CD56-positive haematological neoplasms of the skin: a multicentre study of the Cutaneous Lymphoma Project Group of the European Organisation for Research and Treatment of Cancer. J Clin Pathol (2006) 1.08
Treatment of occupational koilonychia with tazarotene gel. Acta Derm Venereol (2003) 1.07
Phrynoderma: a cutaneous sign of an inadequate diet. CMAJ (2007) 1.06
Facial patterns and primary nocturnal enuresis in children. Sleep Breath (2010) 1.05
Contribution of melanocortin-1 receptor gene variants to sporadic cutaneous melanoma risk in a population in central Italy: a case-control study. Melanoma Res (2006) 1.05
CDKN2A and MC1R mutations in patients with sporadic multiple primary melanoma. J Invest Dermatol (2004) 1.04
Dermoscopic and histopathologic diagnosis of equivocal melanocytic skin lesions: an interdisciplinary study on 107 cases. Cancer (2002) 1.04
Supportive care in patients with advanced non-small-cell lung cancer. Br J Cancer (2003) 1.04
Impact of dermoscopy on the clinical management of pigmented skin lesions. Clin Dermatol (2002) 1.02
Increased frequency of Ig heavy-chain HS1,2-A enhancer *2 allele in dermatitis herpetiformis, plaque psoriasis, and psoriatic arthritis. J Invest Dermatol (2008) 0.99
Nutraceuticals safety and efficacy in migraine without aura in a population of children affected by neurofibromatosis type I. Neurol Sci (2013) 0.99
Identical TCR beta-chain rearrangements in streptococcal angina and skin lesions of patients with psoriasis vulgaris. J Immunol (2006) 0.98
Acupressure therapy for insomnia in adolescents: a polysomnographic study. Neuropsychiatr Dis Treat (2013) 0.98
Imiquimod treatment of superficial and nodular basal cell carcinoma: 12-week open-label trial. Dermatol Surg (2005) 0.96
IL-21 promotes skin recruitment of CD4(+) cells and drives IFN-γ-dependent epidermal hyperplasia. J Immunol (2011) 0.95
Occlusal traits in developmental dyslexia: a preliminary study. Neuropsychiatr Dis Treat (2013) 0.95
Fate of UVB-induced p53 mutations in SKH-hr1 mouse skin after discontinuation of irradiation: relationship to skin cancer development. Oncogene (2005) 0.95
Apremilast for the treatment of psoriasis. Expert Opin Pharmacother (2015) 0.94
Polysomnographic findings in Rett syndrome: a case-control study. Sleep Breath (2012) 0.94
Prospective assessment of body weight and body composition changes in patients with psoriasis receiving anti-TNF-α treatment. Dermatol Ther (2011) 0.94
Re: MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population. J Natl Cancer Inst (2006) 0.92
Topical treatment of actinic keratoses with piroxicam 1% gel: a preliminary open-label study utilizing a new clinical score. Am J Clin Dermatol (2010) 0.92
Immunogenicity of anti-TNFα therapy in psoriasis: a clinical issue? Expert Opin Biol Ther (2013) 0.91
Psychological, cognitive and maternal stress assessment in children with primary ciliary dyskinesia. World J Pediatr (2013) 0.91
Co-localization of susceptibility loci for psoriasis (PSORS4) and atopic dermatitis (ATOD2) on human chromosome 1q21. Hum Hered (2006) 0.91
Erysipeloid cutaneous metastasis from bladder carcinoma. Eur J Dermatol (2007) 0.91
Positional abnormalities during sleep in children affected by obstructive sleep apnea syndrome: the putative role of kinetic muscular chains. Med Hypotheses (2013) 0.91
Interobserver agreement on dermoscopic features of pigmented basal cell carcinoma. Dermatol Surg (2002) 0.91
Acute onset disseminated superficial porokeratosis heralding diffuse large B-cell lymphoma. Eur J Dermatol (2008) 0.90
Psoriatic arthritis and CARD15 gene polymorphisms: no evidence for association in the Italian population. J Invest Dermatol (2004) 0.90
Evidence of increased apoptosis and reduced proliferation in basal cell carcinomas treated with tazarotene. J Invest Dermatol (2004) 0.90
Ustekinumab treatment of erythrodermic psoriasis occurring after physical stress: a report of two cases. Case Rep Dermatol (2013) 0.90
Exclusion of CARD15/NOD2 as a candidate susceptibility gene to psoriasis in the Italian population. Eur J Dermatol (2002) 0.90
Efficacy and safety of subcutaneous anti-tumor necrosis factor-alpha agents, etanercept and adalimumab, in elderly patients affected by psoriasis and psoriatic arthritis: an observational long-term study. Dermatology (2012) 0.90
Psoriasis: from pathogenesis to novel therapeutic approaches. Clin Sci (Lond) (2011) 0.89
Prevention of dermatologic side effects of bimatoprost 0.03% topical therapy. Am J Ophthalmol (2006) 0.89
Imiquimod 5% cream in the treatment of Bowen's disease and invasive squamous cell carcinoma. J Am Acad Dermatol (2006) 0.89
Risk factors of hypertension, diabetes and obesity in Italian psoriasis patients: a survey on socio-demographic characteristics, smoking habits and alcohol consumption. Eur J Dermatol (2009) 0.89
An atypical patient with Cowden syndrome and PTEN gene mutation presenting with cortical malformation and focal epilepsy. Brain Dev (2012) 0.88
Cardiovascular effects of the phytoestrogen genistein. Curr Med Chem Cardiovasc Hematol Agents (2004) 0.88
Granulomatous mycosis fungoides responsive to gemcitabine. Eur J Dermatol (2002) 0.87
Cerebriform plantar hyperplasia: the clinico-pathological hallmark of Proteus syndrome. Acta Derm Venereol (2011) 0.87
Long-term efficacy of adalimumab in generalized pustular psoriasis. J Dermatolog Treat (2008) 0.87
Sleep disordered breathing and airway disease in primary ciliary dyskinesia. Respirology (2014) 0.87
Different applications of monochromatic excimer light in skin diseases. Photomed Laser Surg (2009) 0.87
Efficacy and safety of systemic treatments for psoriasis in elderly patients. Acta Derm Venereol (2014) 0.86
A p38-dependent pathway regulates DeltaNp63 DNA binding to p53-dependent promoters in UV-induced apoptosis of keratinocytes. Oncogene (2005) 0.86
Bowenoid papulosis and invasive Bowen's disease: a multidisciplinary approach. Acta Derm Venereol (2013) 0.86
-174G/C IL-6 gene promoter polymorphism predicts therapeutic response to TNF-α blockers. Pharmacogenet Genomics (2012) 0.86
Cerebral cavernomas in a family with multiple cutaneous and uterine leiomyomas associated with a new mutation in the fumarate hydratase gene. J Invest Dermatol (2007) 0.86
Incidence of psoriasis and association with comorbidities in Italy: a 5-year observational study from a national primary care database. Eur J Dermatol (2010) 0.86
Clobetasol propionate foam 0.05% as a novel topical formulation for plaque-type and scalp psoriasis. J Dermatolog Treat (2007) 0.85
Efalizumab. Expert Opin Drug Saf (2011) 0.84
Scanning for mutations of the ryanodine receptor (RYR1) gene by denaturing HPLC: detection of three novel malignant hyperthermia alleles. Clin Chem (2003) 0.84
Efficacy of short-term cyclosporine treatment to control psoriasis-related events during efalizumab therapy. Dermatology (2008) 0.84
Cyclosporine: a novel therapeutic approach for Burning Mouth Syndrome. G Ital Dermatol Venereol (2015) 0.83
Cross-talks in the p53 family: deltaNp63 is an anti-apoptotic target for deltaNp73alpha and p53 gain-of-function mutants. Cell Cycle (2006) 0.83
Safety of anti-TNFα agents in the treatment of psoriasis and psoriatic arthritis. Immunopharmacol Immunotoxicol (2012) 0.83
Allele-specific cytokine responses at the HLA-C locus: implications for psoriasis. J Invest Dermatol (2011) 0.83
Long-term ustekinumab treatment for refractory type I pityriasis rubra pilaris. J Dermatol Case Rep (2013) 0.83
Effects of acetaminophen and ibuprofen in children with migraine receiving preventive treatment with magnesium. Headache (2013) 0.83